Search
Descriptor English: Triazolam
Descriptor Spanish: Triazolam
Descriptor Portuguese: Triazolam
Descriptor French: Triazolam
Entry term(s): Apo Triazo
Apo-Triazo
Gen Triazolam
Gen-Triazolam
Halcion
Trilam
U 33,030
U-33,030
U33,030
Tree number(s): D03.633.100.079.080.900
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D014229
Scope note: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Adjuvants, Anesthesia
Anti-Anxiety Agents
GABA Modulators
Registry Number: 1HM943223R
CAS Type 1 Name: 4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-6-(2-chlorophenyl)-1-methyl-
Previous Indexing: Benzazepines (1974)
Benzodiazepines (1975-1976)
Triazoles (1974-1976)
Public MeSH Note: 86; was see under BENZODIAZEPINE TRANQUILIZERS 1977-85
History Note: 86(77); was see under BENZODIAZEPINE TRANQUILIZERS 1977-85
DeCS ID: 14624
Unique ID: D014229
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1986/01/01
Date of Entry: 1976/04/16
Revision Date: 2017/05/24
Triazolam - Preferred
Concept UI M0021910
Scope note A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Preferred term Triazolam
U-33,030 - Narrower
Concept UI M0353523
Preferred term U-33,030
Entry term(s) U 33,030
U33,030
Halcion - Narrower
Concept UI M0353522
Preferred term Halcion
Trilam - Narrower
Concept UI M0476884
Preferred term Trilam
Apo-Triazo - Narrower
Concept UI M0476882
Preferred term Apo-Triazo
Entry term(s) Apo Triazo
Gen-Triazolam - Narrower
Concept UI M0476883
Preferred term Gen-Triazolam
Entry term(s) Gen Triazolam



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey